Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Department of Hepatobiliary Hernia Surgery, Liaocheng Dongcangfu People's Hospital, Liaocheng 252000, Shandong Province, China.
World J Gastroenterol. 2024 Mar 7;30(9):1224-1236. doi: 10.3748/wjg.v30.i9.1224.
BACKGROUND: As a critical early event in hepatocellular carcinogenesis, telomerase activation might be a promising and critical biomarker for hepatocellular carcinoma (HCC) patients, and its function in the genesis and treatment of HCC has gained much attention over the past two decades. AIM: To perform a bibliometric analysis to systematically assess the current state of research on HCC-related telomerase. METHODS: The Web of Science Core Collection and PubMed were systematically searched to retrieve publications pertaining to HCC/telomerase limited to "articles" and "reviews" published in English. A total of 873 relevant publications related to HCC and telomerase were identified. We employed the Bibliometrix package in R to extract and analyze the fundamental information of the publications, such as the trends in the publications, citation counts, most prolific or influential writers, and most popular journals; to screen for keywords occurring at high frequency; and to draw collaboration and cluster analysis charts on the basis of coauthorship and co-occurrences. VOSviewer was utilized to compile and visualize the bibliometric data. RESULTS: A surge of 51 publications on HCC/telomerase research occurred in 2016, the most productive year from 1996 to 2023, accompanied by the peak citation count recorded in 2016. Up to December 2023, 35226 citations were made to all publications, an average of 46.6 citations to each paper. The United States received the most citations ( = 13531), followed by China ( = 7427) and Japan ( = 5754). In terms of national cooperation, China presented the highest centrality, its strongest bonds being to the United States and Japan. Among the 20 academic institutions with the most publications, ten came from China and the rest of Asia, though the University of Paris Cité, Public Assistance-Hospitals of Paris, and the National Institute of Health and Medical Research (INSERM) were the most prolific. As for individual contributions, Hisatomi H, Kaneko S, and Ide T were the three most prolific authors. Kaneko S ranked first by H-index, G-index, and overall publication count, while Zucman-Rossi J ranked first in citation count. The five most popular journals were the , , , , and , while , , and had the most citations. We extracted 2293 keywords from the publications, 120 of which appeared more than ten times. The most frequent were HCC, telomerase and human telomerase reverse transcriptase (hTERT). Keywords such as mutational landscape, TERT promoter mutations, landscape, risk, and prognosis were among the most common issues in this field in the last three years and may be topics for research in the coming years. CONCLUSION: Our bibliometric analysis provides a comprehensive overview of HCC/telomerase research and insights into promising upcoming research.
背景:端粒酶激活作为肝细胞癌(HCC)发生的一个关键早期事件,可能是 HCC 患者有前途和关键的生物标志物,其在 HCC 的发生和治疗中的作用在过去二十年中受到了广泛关注。
目的:进行文献计量分析,系统评估与 HCC 相关的端粒酶的研究现状。
方法:系统检索 Web of Science 核心合集和 PubMed 数据库,以获取仅限于“文章”和“综述”类型、发表语言为英语的 HCC/端粒酶相关文献。共确定了 873 篇与 HCC 和端粒酶相关的相关文献。我们使用 R 中的 Bibliometrix 包提取和分析出版物的基本信息,例如出版物的趋势、引文计数、最有影响力的作者和最受欢迎的期刊;筛选高频出现的关键词;并根据合著和共现情况绘制合作和聚类分析图表。VOSviewer 用于编译和可视化文献计量数据。
结果:1996 年至 2023 年期间,关于 HCC/端粒酶研究的出版物数量激增,2016 年达到 51 篇,是最具生产力的一年,同时也是 2016 年记录的最高引文数。截至 2023 年 12 月,所有出版物共被引用 35226 次,平均每篇论文被引用 46.6 次。美国获得的引用最多(=13531),其次是中国(=7427)和日本(=5754)。就国家合作而言,中国的中心度最高,与美国和日本的联系最强。在发表文献最多的 20 所学术机构中,有 10 所来自中国和亚洲其他地区,尽管巴黎一大、巴黎公立医院集团和法国国家健康与医学研究院(INSERM)是最具生产力的机构。就个人贡献而言,Hisatomi H、Kaneko S 和 Ide T 是最有影响力的作者。Kaneko S 以 H-index、G-index 和总发文量排名第一,而 Zucman-Rossi J 以引文数排名第一。最受欢迎的期刊是、、、、和,而、、和则被引用最多。我们从出版物中提取了 2293 个关键词,其中 120 个出现了 10 次以上。最常见的是 HCC、端粒酶和人端粒酶逆转录酶(hTERT)。在过去三年中,突变景观、TERT 启动子突变、景观、风险和预后等关键词是该领域的常见问题,可能是未来几年的研究课题。
结论:我们的文献计量分析提供了 HCC/端粒酶研究的全面概述,并深入了解了有前途的未来研究方向。
World J Gastroenterol. 2024-3-7
Front Immunol. 2023
Front Biosci (Landmark Ed). 2022-8-31
Front Public Health. 2022
Front Public Health. 2022
Medicine (Baltimore). 2025-5-30
World J Gastroenterol. 2024-11-7
Int J Med Inform. 2020-9-19
Hepatology. 2021-1
CA Cancer J Clin. 2020-1-8
Cell Mol Life Sci. 2019-11-14
Quant Imaging Med Surg. 2019-3